PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It is developing ONIVYDE, a proprietary liposome encapsulation of irinotecan, a topoisomerase 1 inhibitor for the treatment of metastatic pancreatic cancer; PEP06, which is in Phase I clinical trial for the treatment of cancer; and PEP07, a Chk1 inhibitor, which is in preclinical development stage to accumulate DNA damage in cells, lead to replication catastrophe, and induce cell apoptosis. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
PharmaEngine Dividend Announcement
• PharmaEngine announced a annually dividend of NT$1.50 per ordinary share which will be made payable on 2024-08-30. Ex dividend date: 2024-08-12
• PharmaEngine annual dividend for 2024 was NT$1.50
• PharmaEngine annual dividend for 2023 was NT$2.00
• PharmaEngine's trailing twelve-month (TTM) dividend yield is 1.45%
• PharmaEngine's payout ratio for the trailing twelve months (TTM) is 80.05%
PharmaEngine Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-12 | NT$1.50 | annually | 2024-08-30 |
2023-08-15 | NT$2.00 | annually | 2023-09-01 |
2022-08-15 | NT$2.70 | annually | 2022-09-02 |
2021-09-13 | NT$2.53 | annually | 2021-09-30 |
2020-07-28 | NT$0.50 | annually | 2020-08-20 |
2019-08-28 | NT$1.00 | annually | 2019-09-20 |
2018-08-27 | NT$2.00 | annually | 2018-09-27 |
2017-07-26 | NT$1.67 | annually | 2017-09-01 |
2016-07-25 | NT$1.66 | annually | |
2015-06-30 | NT$1.00 | annually |
PharmaEngine Dividend per year
PharmaEngine Dividend growth
PharmaEngine Dividend Yield
PharmaEngine current trailing twelve-month (TTM) dividend yield is 1.45%. Interested in purchasing PharmaEngine stock? Use our calculator to estimate your expected dividend yield:
PharmaEngine Financial Ratios
PharmaEngine Dividend FAQ
Other factors to consider when evaluating PharmaEngine as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy PharmaEngine stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: PharmaEngine's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, PharmaEngine publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, PharmaEngine distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from PharmaEngine are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: PharmaEngine sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, PharmaEngine distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: PharmaEngine declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of PharmaEngine's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review PharmaEngine's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.